Optimisation of the hydrolysis of goat milk protein for the production of ACE-inhibitory peptides

Journal of Dairy Research

Volumn 80, Issue 2, 2013, Pages 214-222

  Espejo Carpio, Francisco Javier ^a   Pérez Gálvez, Raúl ^a   Guadix, Emilia M ^a   Guadix, Antonio ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

ACE inhibitory activity; enzymatic hydrolysis; Goat milk protein; optimisation; response surface methodology

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MILK PROTEIN; PEPTIDE; SUBTILISIN; TRYPSIN;

ANIMAL; ARTICLE; GOAT; HYDROLYSIS; METABOLISM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; GOATS; HYDROLYSIS; MILK PROTEINS; PEPTIDES; SUBTILISIN; TRYPSIN;

CAPRA HIRCUS;

EID: 84876119937     PISSN: 00220299     EISSN: 14697629     Source Type: Journal    
DOI: 10.1017/S0022029913000083     Document Type: Article

References (38)

1. Abert T & Kneifel W 1993 Physicochemical and functional properties of protein hydrolysates as obtained by treatment with different enzymes. Adler-Nissen J 1986 Enzymic Hydrolysis of Food Proteins. London: Elsevier Applied Science Publishers
2. Clare DA & Swaisgood HE 2000 Bioactive milk peptides: a prospectus. Journal of Dairy Science 83 1187-1195
3. Contreras MDM, Hernandez-Ledesma B, Amigo L, Martin-Alvarez PJ & Recio I 2011 Production of antioxidant hydrolyzates from a whey protein concentrate with thermolysin: optimisation by response surface methodology. LWT-Food Science Technology 44 9-15
4. De Leo F, Panarese S, Gallerani R & Ceci LR 2009 Angiotensin converting enzyme (ACE) inhibitory peptides: production and implementation of functional food. Current Pharmaceutical Design 15 3622-3643
5. Fitz Gerald RJ & Meisel H 2000 Milk protein-derived peptide inhibitors of angiotensin-I converting enzyme. British Journal of Nutrition 84 S33-S37
6. Foltz M, Cerstiaens A, Van Meensel A, Mols R, Van der Pijl PC, Duchateau GS & Augustijns P 2008 The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models. Peptides 29 1312-1320
7. Geerlings A, Villar IC, Zarco FH, Sánchez M, Vera R, Zafra A, Boza J & Duarte J 2006 Identification and characterisation of novel angiotensinconverting enzyme inhibitors obtained from goat milk. Journal of Dairy Science 89 3326-3335
8. Guadix A, Guadix E, Páez-Dueñas MP, González-Tello P & Camacho F 2000 Procesos tecnológicos y métodos de control en la hidrólisis de proteínas. Technological processes and methods of control in the hydrolysis of proteins. Ars Pharmaceutica 41 79-89
9. Halling PJ 1981 Protein-stabilised foams and emulsions. Critical Reviews in Food Science and Nutrition 15 155-170
10. Halsall-Whitney H & Thibault J 2006 Multi-objective optimization for chemical processes and controller design: approximating and classifying the Pareto Domain. Computers and Chemical Engineering 30 1155-1168
11. IDF 1993 Protein and fat globule modifications by heat treatment, homogenization and other technological means for high quality dairy products. Seminar Proceedings Munich (DE) 25-28 August 1992 pp. 125-131. Brussels: IDF (FID-IDF Special Issue No 9303)
12. Jauhiainen T & Korpela R 2007 Milk peptides and blood pressure. Journal of Nutrition 137 825S-829S
13. Jiang J, Chen S, Ren F, Luo Z & Zeng SS 2007 Yak milk casein as a functional ingredient: preparation and identification of angiotensin-i- converting enzyme inhibitory peptides. Journal of Dairy Research 74 18-25
14. Johnston CI 1992 Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. Journal of Hypertension 10 S13-S26
15. Kilara A & Panyam D 2003 Peptides from milk proteins and their properties. Critical Reviews in Food Science and Nutrition 43 607-633
16. Kim IY & de Weck OL 2005 Adaptive weighted-sum method for bi-objective optimisation: pareto front generation. Structural and Multidisciplinary Optimisation 31 105-106
17. Korhonen H & Philanto A 2003 Food-derived bioactive peptides- Opportunities for designing future foods. Current Pharmaceutical Design 9 1297-1308
18. Li GH, Le GW, Shi YH & Shrestha S 2004 Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutrition Research 24 469-486
19. Lopez AD & Murray CC 1998 The global burden of disease, 1990-2020. Nature Medicine 4 1241-1243
20. Mahmoud MI, Malone WT & Cordle CT 1992 Enzymic hydrolysis of casein: effect of degree of hydrolysis on antigenicity and physical properties. Journal of Food Science 57 1223-1229
21. Mao XY, Ni JR, Sun WL, Hao PP & Fan L 2007 Value-added utilisation of yak milk casein for the production of angiotensin-I-converting enzyme inhibitory peptides. Food Chemistry 103 1282-1287
22. Miguel M, Dávalos A, Manso MA, de la Peña G, Lasunción MA & López-Fandiño R 2008 Transepithelial transport across Caco-2 cell monolayers of antihypertensive egg-derived peptides. PepT1-mediated flux of Tyr-Pro-Ile.Molecular Nutrition and Food Research 12 1507-1513
23. Myers RH, Montgomery DC & Anderson-Cook CM 2009 Response Surface Methodology: Process and Product Optimisation using Designed Experiments. New York: Wiley-Interscience
24. Nielsen PM 1994 Enzyme technology for production of protein based flavours. In Proceedings of the Food Ingredients Europe Conference. pp. 106-111. Maarssen: Process Press Europe
25. Pan D, Cao J, Guo H & Zhao B 2012 Studies on purification and the molecular mechanism of a novel ACE inhibitory peptide from whey protein hydrolysate. Food Chemistry 130 121-126
26. Park YW, Juárez M, Ramos M & Haenlein GFW 2007 Physico-chemical characteristics of goat and sheep milk. Small Ruminant Research 68 88-113
27. Pedersen B 1994 Removing bitterness from protein hydrolysates. Food Technology 48 96-98
28. Perez-Galvez R, Almecija MC, Espejo FJ, Guadix EM & Guadix A 2011 Bi-objective optimisation of the enzymatic hydrolysis of porcine blood protein. Biochemical Engineering Journal 53 305-310
29. Pintado ME & Malcata FX 2000 Hydrolysis of ovine, caprine and bovine whey proteins by trypsin and pepsin. Bioprocess Engineering 23 275-282
30. Potier M & Tomé D 2008 Comparison of digestibility and quality of intact proteins with their respective hydrolysates. Journal of AOAC International 91 1002-1005
31. Roberts PR, Burney JD, Black KW & Zaloga GP 1999 Effect of chain length on absorption of biologically active peptides from the gastrointestinal tract. Digestion 60 332-337
32. Severin S & Xia W 2006 Enzymatic hydrolysis of whey proteins by two different proteases and their effect on the functional properties of resulting protein hydrolysates. Journal of Food Biochemistry 30 77-97
33. Shalaby SM, Zakora M & Otte J 2006 Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates. Journal of Dairy Research 73 178-186
34. Sipos T & Merkel JR 1970 An effect of calcium ions on the activity, heat stability, and structure of trypsin. Biochemistry 9 2766-2775
35. Tauzin J, Miclo L & Gaillard JL 2002 Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine αS2-casein. FEBS Letters 531 369-374
36. Tavares TG, Contreras MM, Amorim M, Martín-Álvarez PJ, Pintado ME, Recio I & Malcata FX 2011 Optimisation, by response surface methodology, of degree of hydrolysis and antioxidant and ACE-inhibitory activities of whey protein hydrolysates obtained with cardoon extract. International Dairy Journal 21 926-933
37. Tuncturk Y & Zorba O 2006 The effects of enzymatic hydrolysis of casein on apparent yield stress and some emulsion properties. Food Hydrocolloids 20 475-482
38. Van der Ven C, Gruppen H, de Bont D & Voragen A 2002 Optimisation of the angiotensin converting enzyme inhibition by whey protein hydrolysates using response surface methodology. International Dairy Journal 12 813-820